HnRNPA2/B1 also reduced the sensitivity of breast cancer cells to olaparib by interacting with m6A sites in the 3′UTR of autophagy gene ATG4B to induce degradation [142]. The gene discussed is HNRNPA2B1; the disease is breast carcinoma.